Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00512551 · ClinicalTrials.gov registry record
DNA Array Analysis of Patients With Cervical Cancer
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 18
- Enrollment target
NCT00512551: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00512551 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 18 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00512551 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 18 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to find out if the expression of certain genes is linked with the response of cervical cancer to radiation. Researchers will study a large number of genes located in tumor material to learn this information.
Interventions
- PROCEDURE Tumor Biopsies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2000-06-20 |
| Est. Completion | 2017-11-20 |
What the finished NCT00512551 record still lists
NCT00512551 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 18 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Tumor Biopsies is the first listed.
NCT00512551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00512551 about?
NCT00512551 is a clinical study titled "DNA Array Analysis of Patients With Cervical Cancer". The goal of this clinical research study is to find out if the expression of certain genes is linked with the response of cervical cancer to radiation. Researchers will study a large number of genes located in tumor material to learn this information.
What is the current status of trial NCT00512551?
This trial is currently completed. The enrollment target is 18 participants. The study started on 2000-06-20. Estimated completion is 2017-11-20.
What interventions are being tested in trial NCT00512551?
The interventions under investigation include: Tumor Biopsies (PROCEDURE).
Who is sponsoring clinical trial NCT00512551?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01245179 · 18 participants · Phase 1
Study of Panobinostat (LBH589) in Patients With Sickle Cell Disease
- NCT01999361 · 18 participants · NA
Prevention of de Novo Allosensitization in Islet Transplant Recipients Following Complete Graft Loss
- NCT02359825 · 18 participants · Phase 1
Nerve Repair Using Hydrophilic Polymers to Promote Immediate Fusion of Severed Axons and Swift Return of Function
- NCT02870244 · 18 participants · Phase 1
Adoptive T Cell Immunotherapy for Advanced Melanoma Using Engineered Lymphocytes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI